# Brett Wingeier

> Brett Wingeier is a San Francisco-based engineer, inventor and company builder who co-founded Halo Neuroscience and Magnus Medical, serving as Magnus’s founding CEO. He returned to NeuroPace in September 2024 as Vice President of Research and Development. His public career spans research, embedded software, product development, manufacturing and company leadership.

- **Role:** Vice President of Research and Development at NeuroPace
- **Organizations:** NeuroPace, Magnus Medical, Halo Neuroscience, LT2 Labs, German International School of Silicon Valley, Celero Systems
- **Education:** Bachelor of Science in Engineering, Biomedical Engineering, Tulane University, PhD, Biomedical Engineering, Tulane University, Postgraduate research fellowship, brain physics and EEG, Swinburne University of Technology, Brain Sciences Institute, Biodesign studies; no degree stated, Stanford University
- **Known for:** Co-founded Halo Neuroscience and Magnus Medical., Served as Magnus’s founding CEO and also held its CTO role., More than 70 issued patents reported by NeuroPace in September 2024.

## Career timeline

- **1996** — Completed his undergraduate engineering degree at Tulane.
- **1998-2001** — Undertook postgraduate research at the Brain Sciences Institute in Melbourne.
- **2001-2013** — Worked at NeuroPace, ultimately as Principal Biomedical Engineer.
- **2004** — Completed his PhD in biomedical engineering at Tulane.
- **2008-2013** — Ran Wingeier Biomedical Consulting alongside his other work.
- **2012** — Became a registered US patent agent in June; registration number 69895.
- **2013** — Co-founded Halo Neuroscience with Daniel Chao.
- **2016** — Halo began shipping its wearable product late in the year.
- **2017-2023** — Served on the German International School of Silicon Valley board, including chairing its risk management committee.
- **2019** — Halo collaborated with Berklee College of Music on musical learning and practice.
- **2020** — Co-founded Magnus Medical with Brandon Bentzley; served as its founding CEO.
- **2021** — Magnus announced $25 million in Series A financing, co-led by JAZZ Venture Partners and Red Tree Venture Capital.
- **2023** — Participated in the World Science Festival’s March 9 discussion moderated by Brian Greene.
- **2024** — Established LT2 Labs; rejoined NeuroPace as VP of Research and Development effective September 4.
- **2026** — Named as a co-inventor on US patent 12,558,534, issued February 24.

## Achievements

- Co-founded Halo Neuroscience and Magnus Medical.
- Served as Magnus’s founding CEO and also held its CTO role.
- More than 70 issued patents reported by NeuroPace in September 2024.
- Registered US patent agent, registration number 69895.
- Returned to NeuroPace to lead research and development in September 2024.
- Participated in World Science Festival programming with Brian Greene, Takao Hensch and John Krakauer.

## Latest updates

- **2026-02** — US patent 12,558,534 was issued with Wingeier and five collaborators listed as inventors; assignee Flow Neuroscience, Inc. This is a patent event, not evidence of a new employment role.
- **2024-09** — NeuroPace announced his appointment as Vice President of Research and Development, effective September 4.

## Links

- LinkedIn: https://www.linkedin.com/in/wingeier/
- Twitter/X: https://x.com/wingeier

---

Profile page: https://yespress.io/brett-wingeier
Published by YesPress — https://yespress.io
Last updated: 2026-10-23